507
Views
14
CrossRef citations to date
0
Altmetric
Inflammatory bowel disease

Patients' information-seeking activity is associated with treatment compliance in inflammatory bowel disease patients

, , , , , , , & show all
Pages 662-673 | Received 09 Jan 2014, Accepted 13 Feb 2014, Published online: 12 Mar 2014

References

  • Vavricka SR, Brun L, Ballabeni P, et al. Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol 2011;106:110–19.
  • Jackson CA, Clatworthy J, Robinson A, et al. Factors associated with non-adherence to oral medication for inflammatory bowel disease: a systematic review. Am J Gastroenterol 2010;105:525–39.
  • Ediger JP, Walker JR, Graff L, et al. Predictors of medication adherence in inflammatory bowel disease. Am J Gastroenterol 2007;102:1417–26.
  • D'Inca R, Bertomoro P, Mazzocco K, et al. Risk factors for non-adherence to medication in inflammatory bowel disease patients. Aliment Pharmacol Ther 2008;27:166–72.
  • Nahon S, Lahmek P, Saas C, et al. Socioeconomic and psychological factors associated with nonadherence to treatment in inflammatory bowel disease patients: results of the ISSEO survey. Inflamm Bowel Dis 2011;17:1270–6.
  • Kane SV. Strategies to improve adherence and outcomes in patients with ulcerative colitis. Drugs 2008;68:2601–9.
  • Sewitch MJ, Abrahamowicz M, Barkun A, et al. Patient nonadherence to medication in inflammatory bowel disease. Am J Gastroenterol 2003;98:1535–44.
  • Nguyen GC, LaVeist TA, Harris ML, et al. Patient trust-in-physician and race are predictors of adherence to medical management in inflammatory bowel disease. Inflamm Bowel Dis 2009;15:1233–9.
  • Kane SV, Cohen RD, Aikens JE, et al. Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis. Am J Gastroenterol 2001;96:2929–33.
  • Bhatt J, Patil S, Joshi A, et al. Self-reported treatment adherence in inflammatory bowel disease in Indian patients. Indian J Gastroenterol 2009;28:143–6.
  • Casati J, Toner BB, de Rooy EC, et al. Concerns of patients with inflammatory bowel disease: a review of emerging themes. Dig Dis Sci 2000;45:26–31.
  • Mansfield JC, Tanner AR, Bramble MG. Information for patients about inflammatory bowel disease. J R Coll Physicians Lond 1997;31:184–7.
  • Marshall JG. The information needs of patients with Crohn's disease. Patient Couns Health Educ 1979;1:142–5.
  • Martin A, Leone L, Castagliuolo I, et al. What do patients want to know about their inflammatory bowel disease? Ital J Gastroenterol 1992;24:477–80.
  • Politi P, Bodini P, Mortilla MG, et al. Communication of information to patients with inflammatory bowel disease: A European Collaborative Study in a multinational prospective inception cohort. J Crohns Colitis 2008;2:226–32.
  • Kane S, Dixon L. Adherence rates with infliximab therapy in Crohn's disease. Aliment Pharmacol Ther 2006;24:1099–103.
  • Kane SV. Systematic review: adherence issues in the treatment of ulcerative colitis. Aliment Pharmacol Ther 2006;23:577–85.
  • Carpenter DM, DeVellis RF, Fisher EB, et al. The effect of conflicting medication information and physician support on medication adherence for chronically ill patients. Patient Educ Couns 2010;81:169–76.
  • Horne R. Concordance, adherence and compliance in medicine taking: a conceptual map and research priorities. London: National Coordinating Center for NHS Service Delivery and Organistion (NCCSDO); 2006.
  • Pittet V, Juillerat P, Mottet C, et al. Cohort profile: the Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS). Int J Epidemiol 2009;38:922–31.
  • Flanagan JC. The critical incident technique. Psychol Bull 1954;51:327–58.
  • Pourin C, Daucourt V, Barberger-Gateau P. [Use of the critical incident technique in the development of a measurement tool for satisfaction in psychiatry]. Sante Publique 2001;13:169–77.
  • Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361–70.
  • Gasche C, Scholmerich J, Brynskov J, et al. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000;6:8–15.
  • Angelucci E, Orlando A, Ardizzone S, et al. Internet use among inflammatory bowel disease patients: an Italian multicenter survey. Eur J Gastroenterol Hepatol 2009;21:1036–41.
  • Whelan T, Levine M, Willan A, et al. Effect of a decision aid on knowledge and treatment decision making for breast cancer surgery: a randomized trial. JAMA 2004;292:435–41.
  • Molenaar S, Sprangers MA, Rutgers EJ, et al. Decision support for patients with early-stage breast cancer: effects of an interactive breast cancer CDROM on treatment decision, satisfaction, and quality of life. J Clin Oncol 2001;19:1676–87.
  • Borgaonkar MR, Townson G, Donnelly M, et al. Providing disease-related information worsens health-related quality of life in inflammatory bowel disease. Inflamm Bowel Dis 2002;8:264–9.
  • van der Marel S, Duijvestein M, Hardwick JC, et al. Quality of web-based information on inflammatory bowel diseases. Inflamm Bowel Dis 2009;15:1891–6.
  • Bernard A, Langille M, Hughes S, et al. A systematic review of patient inflammatory bowel disease information resources on the World Wide Web. Am J Gastroenterol 2007;102:2070–7.
  • Langille M, Bernard A, Rodgers C, et al. Systematic review of the quality of patient information on the internet regarding inflammatory bowel disease treatments. Clin Gastroenterol Hepatol 2010;8:322–8.
  • Rubin DT, Siegel CA, Kane SV, et al. Impact of ulcerative colitis from patients' and physicians' perspectives: Results from the UC: NORMAL survey. Inflamm Bowel Dis 2009;15:581–8.
  • Olmstead J. Oral 5-aminosalicylic acid therapy for mild-to-moderate ulcerative colitis. J Am Acad Nurse Pract 2010;22:586–92.
  • Kane SV, Robinson A. Review article: understanding adherence to medication in ulcerative colitis - innovative thinking and evolving concepts. Aliment Pharmacol Ther 2010;32:1051–8.
  • Husain A, Triadafilopoulos G. Communicating with patients with inflammatory bowel disease. Inflamm Bowel Dis 2004;10:444–50. discussion 451.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.